CEBPA and acute myeloid leukemia: CCAAT/enhancer binding protein alpha (CEBPA) alterations are more prevalent in hematologic malignancies,27 where CEBPA mutations have been associated with improved outcomes in pediatric and adult acute myeloid leukemia.28